Jul 26, 2016 8:00am EDT Pieris Pharmaceuticals Appoints Julian Adams, Ph.D., to Its Board of Directors
Jun 14, 2016 7:59am EDT Pieris Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
May 11, 2016 5:00pm EDT Pieris Pharmaceuticals Reports Financial Results and Corporate Update for the First Quarter Ended March 31, 2016
Apr 27, 2016 8:00am EDT Pieris Pharmaceuticals to Host First Quarter 2016 Investor Call and Corporate Update on May 12, 2016
Mar 22, 2016 4:05pm EDT Pieris Pharmaceuticals Reports Full-Year 2015 Financial Results and Corporate Update
Mar 17, 2016 8:00am EDT Pieris Pharmaceuticals Announces Presentation of In Vivo Preclinical Data for Its Lead Bispecific Immuno-Oncology Drug Candidate, PRS-343, at the 2016 Annual Meeting of the American Association for Cancer Research (AACR)
Mar 03, 2016 8:00am EST Pieris Pharmaceuticals to Host Full-Year 2015 Investor Call and Corporate Update on March 23, 2016
Mar 02, 2016 8:00am EST Pieris Pharmaceuticals to Present at the Cowen & Company 36th Annual Healthcare Conference on March 9th at 10:00 am ET
